AMG0001

· AnGes USA, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AMG0001, covering 2019-08-13 to 2021-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers [Phase 2]